
Lineage Cell Therapeutics Inc (LCTX)
AMEX
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -12.651 | -33.459 | -10.31 | -17.692 | -30.457 | -17.621 | -19.126 | -17.372 |
Return on Equity (%) | -13.554 | -35.858 | -11.508 | -20.011 | -46.251 | -32.27 | -32.078 | -26.769 |
Return on Invested Capital (%) | -232.573 | -298.085 | -27.259 | -24.583 | -53.021 | -28.294 | -37.037 | -31.095 |
Operating Margin (%) | -649.306 | -941.079 | -547.198 | -1200.657 | -996.775 | -175.556 | -260.279 | -195.621 |
Net Profit Margin (%) | -577.675 | -922.013 | -333.115 | -1130.832 | -990.993 | -178.691 | -240.201 | -195.905 |
Book Value Per Share | 1.24 | 0.701 | 0.349 | 0.244 | 0.197 | 0.086 | 0.027 | 0.105 |
Earnings Per Share | -0.157 | -0.362 | -0.078 | -0.135 | -0.254 | -0.154 | -0.123 | -0.099 |
Cash Per Share | 0.29 | 0.186 | 0.063 | 0.213 | 0.329 | 0.067 | 0.203 | 0.242 |
Working Capital Per Share | 0.282 | 0.232 | 0.341 | 0.237 | 0.38 | 0.241 | 0.117 | 0.196 |
Operating Profit Per Share | 0.026 | 0.037 | 0.021 | 0.009 | 0.022 | 0.086 | 0.051 | 0.049 |
EBIT Per Share | -0.184 | -0.371 | -0.128 | -0.143 | -0.255 | -0.152 | -0.133 | -0.098 |
EBITDA Per Share | -0.184 | -0.371 | -0.128 | -0.143 | -0.255 | -0.152 | -0.133 | -0.098 |
Free Cash Flow Per Share | -0.173 | -0.362 | -0.095 | -0.148 | -0.257 | -0.156 | -0.123 | -0.099 |
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 126,87M | 127,14M | 149,8M | 153,1M | 169,48M | 170,09M | N/A | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -260.142 | N/A | N/A | N/A | -454.155 | N/A | N/A | N/A |
Net Profit Margin (%) | -183.236 | N/A | N/A | N/A | -453.047 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 103,13M |
Ratio cours/bénéfice | -5,03 |
Ratio prix/ventes | 9,86 |
Ratio prix/liquidités | 2,04 |
Ratio prix/valeur comptable | 1,22 |
Rendement de dividende | - |
Actions en circulation | 228,36M |
Volume moyen (1 semaine) | 1,33M |
Volume moyen (1 mois) | 1,71M |
Variation sur 52 semaines | -71,81% |
Plus haut sur 52 semaines | 1,56 |
Plus bas sur 52 semaines | 0,414 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales